SCHEMBL7975243

SCHEMBL7975243

Cc1cccc(Cn2cnc3[nH]c(-c4cccc(Cl)c4)nc(=O)c32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GLA P06280 1/20 0.44
UBE2N P61088 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
P2RX7 Q99572 4/20 0.42
ACP1 P24666 2/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973628 0.93 SMN1; SMN2 (0.48) HTTSMN1; SMN2GLAUBE2NL3MBTL1
SCHEMBL7991600 0.92 ACP1 (0.42) HTTSMN1; SMN2GLAUBE2NL3MBTL1
SCHEMBL7974015 0.91 PARN (0.49) HTTSMN1; SMN2GLAUBE2NL3MBTL1
SCHEMBL7988597 0.90 PARN (0.48) SMN1; SMN2TP53MAPTALDH1A1HPGD
SCHEMBL7974270 0.90 ALDH1A1 (0.46) HTTSMN1; SMN2TP53MAPTALDH1A1
SCHEMBL7991561 0.89 HPGD (0.43) HTTSMN1; SMN2TP53MAPTALDH1A1
SCHEMBL7985362 0.88 GRIN1 (0.45) HTTSMN1; SMN2GLAUBE2NL3MBTL1
SCHEMBL7988962 0.88 GRIN1 (0.44) HTTSMN1; SMN2POLBGRIN1GRIN2B
SCHEMBL7974249 0.88 ALDH1A1 (0.41) HTTSMN1; SMN2MAPTALDH1A1HPGD
SCHEMBL7988669 0.88 PARN (0.48) HTTSMN1; SMN2GLAUBE2NL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed